Different phenotypes in human prostate cancer: α6 or α3 integrin in cell-extracellular adhesion sites

Monika Schmelz, Anne E. Cress, Katherine M. Scott, Friederike Bürgery, Haiyan Cui, Karim Sallam, Kathy M. McDaniel, Bruce L. Dalkin, Raymond B. Nagle

Research output: Contribution to journalArticle

63 Scopus citations

Abstract

The distribution of α6/α3 integrin in adhesion complexes at the basal membrane in human normal and cancer prostate glands was analyzed in 135 biopsies from 61 patients. The levels of the polarized α6/α3 integrin expression at the basal membrane of prostate tumor glands were determined by quantitative immunohistochemistry. The α6/α3 integrin expression was compared with Gleason sum score, pathological stage, and preoperative serum prostate-specific antigen (PSA). The associations were assessed by statistical methods. Eighty percent of the tumors expressed the α6 or α3 integrin and 20% was integrin-negative. Gleason sum score, but not serum PSA, was associated with the integrin expression. Low Gleason sum score correlated with increased integrin expression, high Gleason sum score with low and negative integrin expression. Three prostate tumor phenotypes were distinguished based on differential integrin expression. Type I coexpressed both α6 and α3 subunits, type II exclusively expressed α6 integrin, and type III expressed α3 integrin only. Fifteen cases were further examined for the codistribution of vinculin, paxillin, and CD 151 on frozen serial sections using confocal laser scanning microscopy. The α6/α3 integrins, CD151, paxillin, and vinculin were present within normal glands. In prostate carcinoma, α6 integrin was colocalized with CD 151, but not with vinculin or paxillin. In tumor phenotype I, the α6 subunit did not colocalize with the α3 subunit indicating the existence of two different adhesion complexes. Human prostate tumors display on their cell surface the α6β1 and/or α3β1 integrins. Three tumor phenotypes associated with two different adhesion complexes were identified, suggesting a reorganization of cell adhesion structures in prostate cancer.

Original languageEnglish (US)
Pages (from-to)243-254
Number of pages12
JournalNeoplasia
Volume4
Issue number3
DOIs
StatePublished - May 28 2002

Keywords

  • CD 151
  • Focal adhesion proteins
  • Prostate cancer
  • α6/α3 integrin

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Different phenotypes in human prostate cancer: α6 or α3 integrin in cell-extracellular adhesion sites'. Together they form a unique fingerprint.

  • Cite this